Examining the Potential of C-type Lectin-like Receptors (CLRs) as Immunotherapy Targets
Centre for Experimental Medicine
Dr S Orr
20 January 2019
Invasive fungal infections kill more people per year than TB or malaria. Immunosuppressed patients (cancer patients undergoing chemotherapy, acute myeloid leukaemia, HIV, bone marrow transplant patients) are at high risk of developing invasive fungal infections.